These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 26286117)

  • 1. Immunosuppressive human anti-CD83 monoclonal antibody depletion of activated dendritic cells in transplantation.
    Seldon TA; Pryor R; Palkova A; Jones ML; Verma ND; Findova M; Braet K; Sheng Y; Fan Y; Zhou EY; Marks JD; Munro T; Mahler SM; Barnard RT; Fromm PD; Silveira PA; Elgundi Z; Ju X; Clark GJ; Bradstock KF; Munster DJ; Hart DN
    Leukemia; 2016 Mar; 30(3):692-700. PubMed ID: 26286117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD83 Antibody Inhibits Human B Cell Responses to Antigen as well as Dendritic Cell-Mediated CD4 T Cell Responses.
    Wong KY; Baron R; Seldon TA; Jones ML; Rice AM; Munster DJ
    J Immunol; 2018 May; 200(10):3383-3396. PubMed ID: 29643191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell Population.
    Ju X; Silveira PA; Hsu WH; Elgundi Z; Alingcastre R; Verma ND; Fromm PD; Hsu JL; Bryant C; Li Z; Kupresanin F; Lo TH; Clarke C; Lee K; McGuire H; Fazekas de St Groth B; Larsen SR; Gibson J; Bradstock KF; Clark GJ; Hart DN
    J Immunol; 2016 Dec; 197(12):4613-4625. PubMed ID: 27837105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody to the dendritic cell surface activation antigen CD83 prevents acute graft-versus-host disease.
    Wilson J; Cullup H; Lourie R; Sheng Y; Palkova A; Radford KJ; Dickinson AM; Rice AM; Hart DN; Munster DJ
    J Exp Med; 2009 Feb; 206(2):387-98. PubMed ID: 19171763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Buhlman J; Xu J; Flavell RA; Korngold R; Noelle R; Vallera DA
    J Immunol; 1997 Jan; 158(1):29-39. PubMed ID: 8977172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of acute graft-versus-host disease in a xenogeneic SCID mouse model by the humanized anti-CD74 antagonistic antibody milatuzumab.
    Chen X; Chang CH; Stein R; Cardillo TM; Gold DV; Goldenberg DM
    Biol Blood Marrow Transplant; 2013 Jan; 19(1):28-39. PubMed ID: 23025988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CMRF-44 antibody-mediated depletion of activated human dendridic cells: a potential means for improving allograft survival.
    Koppi T; Munster DJ; Brown L; MacDonald KP; Hart DN
    Transplantation; 2003 May; 75(10):1723-30. PubMed ID: 12777863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients.
    Blazar BR; Sharpe AH; Chen AI; Panoskaltsis-Mortari A; Lees C; Akiba H; Yagita H; Killeen N; Taylor PA
    Blood; 2003 May; 101(9):3741-8. PubMed ID: 12521997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infusion of anti-B7.1 (CD80) and anti-B7.2 (CD86) monoclonal antibodies inhibits murine graft-versus-host disease lethality in part via direct effects on CD4+ and CD8+ T cells.
    Blazar BR; Sharpe AH; Taylor PA; Panoskaltsis-Mortari A; Gray GS; Korngold R; Vallera DA
    J Immunol; 1996 Oct; 157(8):3250-9. PubMed ID: 8871619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human CD83-targeted chimeric antigen receptor T cells prevent and treat graft-versus-host disease.
    Shrestha B; Walton K; Reff J; Sagatys EM; Tu N; Boucher J; Li G; Ghafoor T; Felices M; Miller JS; Pidala J; Blazar BR; Anasetti C; Betts BC; Davila ML
    J Clin Invest; 2020 Sep; 130(9):4652-4662. PubMed ID: 32437331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human T lymphoblasts and activated dendritic cells in the allogeneic mixed leukocyte reaction are susceptible to NK cell-mediated anti-CD83-dependent cytotoxicity.
    Munster DJ; MacDonald KP; Kato M; Hart DJ
    Int Immunol; 2004 Jan; 16(1):33-42. PubMed ID: 14688058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppression involving soluble CD83 induces tolerogenic dendritic cells that prevent cardiac allograft rejection.
    Ge W; Arp J; Lian D; Liu W; Baroja ML; Jiang J; Ramcharran S; Eldeen FZ; Zinser E; Steinkasserer A; Chou P; Brand S; Nicolette C; Garcia B; Wang H
    Transplantation; 2010 Dec; 90(11):1145-56. PubMed ID: 20861805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolongation of cardiac and islet allograft survival by a blocking hamster anti-mouse CXCR3 monoclonal antibody.
    Uppaluri R; Sheehan KC; Wang L; Bui JD; Brotman JJ; Lu B; Gerard C; Hancock WW; Schreiber RD
    Transplantation; 2008 Jul; 86(1):137-47. PubMed ID: 18622291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APCs in the liver and spleen recruit activated allogeneic CD8+ T cells to elicit hepatic graft-versus-host disease.
    Zhang Y; Shlomchik WD; Joe G; Louboutin JP; Zhu J; Rivera A; Giannola D; Emerson SG
    J Immunol; 2002 Dec; 169(12):7111-8. PubMed ID: 12471148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD83 expression is a sensitive marker of activation required for B cell and CD4+ T cell longevity in vivo.
    Prazma CM; Yazawa N; Fujimoto Y; Fujimoto M; Tedder TF
    J Immunol; 2007 Oct; 179(7):4550-62. PubMed ID: 17878352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation.
    Kim EY; Lee EN; Lee J; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Joh JW; Kim SJ
    Exp Mol Med; 2006 Jun; 38(3):284-94. PubMed ID: 16819287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of B70/B7-2 in CD4+ T-cell immune responses induced by dendritic cells.
    Fagnoni FF; Takamizawa M; Godfrey WR; Rivas A; Azuma M; Okumura K; Engleman EG
    Immunology; 1995 Jul; 85(3):467-74. PubMed ID: 7558137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane-bound and soluble porcine CD83 functions antithetically in T cell activation and dendritic cell differentiation in vitro.
    Huo S; Zhang J; Liang S; Wu F; Zuo Y; Cui D; Zhang Y; Zhong Z; Zhong F
    Dev Comp Immunol; 2019 Oct; 99():103398. PubMed ID: 31121186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory properties of FK734, a humanized anti-CD28 monoclonal antibody with agonistic and antagonistic activities.
    Shiao SL; McNiff JM; Masunaga T; Tamura K; Kubo K; Pober JS
    Transplantation; 2007 Feb; 83(3):304-13. PubMed ID: 17297405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
    Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
    Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.